Copyright
©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 493-502
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Feature | n (%) |
Anticoagulation | |
Heparin only | 12 (34) |
Bivalirudin | 8 (23) |
Heparin + GP IIb IIIa inhibitor | 15 (43) |
Thrombectomy | 20 (57) |
Distal protection device | 9 (26) |
Number of stents (mean ± SD) | 2.1 ± 1.3 |
Total stent length (mean ± SD) | 52 ± 35 mm |
Stent type | |
Drug-eluting | 19 (55) |
Bare metal | 11 (31) |
None | 5 (14) |
Procedural outcome | |
Success | 29 (83) |
Failed | 6 (17) |
Procedural complications | |
Distal embolization | 1 (3) |
No reflow | 5 (15) |
In-hospital MACE | |
Death | 2 (5.7) |
Myocardial infarction | 1 (2.9) |
Stroke | 0 |
Repeat PCI or CABG | 0 |
Any MACE | 3 (8.6) |
- Citation: Nardone EW, Madsen BM, McCarey MM, Fischman DL, Ruggiero NJ, Walinsky P, Vishnevsky A, Savage MP. Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility? World J Cardiol 2021; 13(9): 493-502
- URL: https://www.wjgnet.com/1949-8462/full/v13/i9/493.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i9.493